All Relations between cocaine and cud

Publication Sentence Publish Date Extraction Date Species
Lauren S Bailey, Jared R Bagley, James D Wherry, Elissa J Chesler, Anushree Karkhanis, James D Jentsch, Lisa M Tarantin. Repeated dosing with cocaine produces strain-dependent effects on responding for conditioned reinforcement in Collaborative Cross mice. Psychopharmacology. 2022-10-14. PMID:36239767. cocaine use disorder (cud) is a highly heritable form of substance use disorder, with genetic variation accounting for a substantial proportion of the risk for transitioning from recreational use to a clinically impairing addiction. 2022-10-14 2023-08-14 mouse
Ahmet O Ceceli, Yuefeng Huang, Greg Kronberg, Pias Malaker, Pazia Miller, Sarah King, Pierre Olivier Gaudreault, Natalie McClain, Lily Gabay, Devarshi Vasa, Jeffrey H Newcorn, Defne Ekin, Nelly Alia-Klein, Rita Z Goldstei. Common and distinct fronto-striatal volumetric changes in heroin and cocaine use disorders. Brain : a journal of neurology. 2022-10-06. PMID:36200376. we hypothesized parallel gray matter volume (gmv) changes associated with human heroin or cocaine use disorder (hud/cud): lower gmv of vmpfc/nacc in hud and ifg in cud, and putamen gmv to be associated with addiction severity measures (including craving) across both. 2022-10-06 2023-08-14 human
Elizabeth K C Schwartz, Noah R Wolkowicz, Joao P De Aquino, R Ross MacLean, Mehmet Sofuogl. Cocaine Use Disorder (CUD): Current Clinical Perspectives. Substance abuse and rehabilitation. vol 13. 2022-09-12. PMID:36093428. cocaine use disorder (cud): current clinical perspectives. 2022-09-12 2023-08-14 Not clear
Elizabeth K C Schwartz, Noah R Wolkowicz, Joao P De Aquino, R Ross MacLean, Mehmet Sofuogl. Cocaine Use Disorder (CUD): Current Clinical Perspectives. Substance abuse and rehabilitation. vol 13. 2022-09-12. PMID:36093428. cocaine use disorder (cud) is a devastating disorder, impacting both individuals and society. 2022-09-12 2023-08-14 Not clear
Elizabeth K C Schwartz, Noah R Wolkowicz, Joao P De Aquino, R Ross MacLean, Mehmet Sofuogl. Cocaine Use Disorder (CUD): Current Clinical Perspectives. Substance abuse and rehabilitation. vol 13. 2022-09-12. PMID:36093428. in this review, we provide an overview of cud, including risk factors for cud, common co-occurring disorders, acute and chronic effects of cocaine use, and currently available pharmacological and behavioral treatments. 2022-09-12 2023-08-14 Not clear
Jane E Joseph, Nicholas Bustos, Kathleen Crum, Julianne Flanagan, Nathaniel L Baker, Karen Hartwell, Megan Moran Santa-Maria, Kathleen Brady, Aimee McRae-Clar. Oxytocin moderates corticolimbic social stress reactivity in cocaine use disorder and healthy controls. Comprehensive psychoneuroendocrinology. vol 11. 2022-08-15. PMID:35967924. the present study examined the effect of intransasal ot (24 iu) versus placebo (pbo) on corticolimbic functional connectivity associated with acute social stress in individuals with cocaine use disorder (cud; n = 67) and healthy controls (hc; n = 52). 2022-08-15 2023-08-14 Not clear
Andrea Miuli, Gianluca Mancusi, Mauro Pettorruso, Francesco Di Carlo, Katia Clemente, Ilenia Di Meo, Antea d'Andrea, Giulia Pernaci, Teresa Di Crosta, Giacomo d'Andrea, Giovanna Bubbico, Giovanni Martinotti, Massimo di Giannantoni. Impact of sleep disorders and disease duration on neurotrophins levels in cocaine use disorder. Neuroscience letters. 2022-07-19. PMID:35850320. convergent lines of evidence suggest neurotrophins alterations could be involved into the pathophysiology of cocaine use disorder (cud) and insomnia. 2022-07-19 2023-08-14 Not clear
Wenchao Li, Chun Zhang, Yang Yang Wang, Lifei Xiao, Yan Feng, Xianhao Huo, Chaofan Wang, Yu Sun, Feng Wang, Tao Su. Alterations of RNAs in the insula related to cocaine-induced condition place preference in adolescent mice. Biochemical and biophysical research communications. vol 621. 2022-07-12. PMID:35820280. it reminds us that cocaine may have a potential role in post-transcriptional regulation, but the alteration of insula-expression profile in adolescent cocaine use disorder (cud) has not been reported. 2022-07-12 2023-08-14 mouse
Andrea Cippitelli, Gilles Zribi, Lawrence Tol. PPL-103: A mixed opioid partial agonist with desirable anti-cocaine properties. Progress in neuro-psychopharmacology & biological psychiatry. 2022-07-07. PMID:35798174. cocaine use disorder (cud) is a persistent public health problem for which no effective medications are available. 2022-07-07 2023-08-14 rat
Andrea Cippitelli, Gilles Zribi, Lawrence Tol. PPL-103: A mixed opioid partial agonist with desirable anti-cocaine properties. Progress in neuro-psychopharmacology & biological psychiatry. 2022-07-07. PMID:35798174. because chronic cocaine use induces changes in the kappa opioid receptor/dynorphin system, we hypothesized that a kappa partial agonist, such as ppl-103, would attenuate the aversive properties of the upregulated kappa system, resulting in effective treatment approach for cud. 2022-07-07 2023-08-14 rat
Andrea Cippitelli, Gilles Zribi, Lawrence Tol. PPL-103: A mixed opioid partial agonist with desirable anti-cocaine properties. Progress in neuro-psychopharmacology & biological psychiatry. 2022-07-07. PMID:35798174. we tested the effects of ppl-103 on cocaine self-administration models that recapitulate core aspects of cud in humans. 2022-07-07 2023-08-14 rat
Fang Zheng, Zhenyu Jin, Jing Deng, Xiabin Chen, Xirong Zheng, Guojun Wang, Kyungbo Kim, Linyue Shang, Ziyuan Zhou, Chang-Guo Zha. Development of a Highly Efficient Long-Acting Cocaine Hydrolase Entity to Accelerate Cocaine Metabolism. Bioconjugate chemistry. 2022-06-29. PMID:35767675. it is particularly challenging to develop a truly effective pharmacotherapy for cocaine use disorder (cud) treatment. 2022-06-29 2023-08-14 Not clear
María Flores-López, Nuria García-Marchena, Pedro Araos, Nerea Requena-Ocaña, Oscar Porras-Perales, Sandra Torres-Galván, Juan Suarez, Nieves Pizarro, Rafael de la Torre, Gabriel Rubio, Juan Jesús Ruiz-Ruiz, Fernando Rodríguez de Fonseca, Antonia Serrano, Francisco Javier Pavón-Moró. Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders. Brain sciences. vol 12. issue 5. 2022-05-28. PMID:35624975. the sud group was divided according to the diagnosis of aud and/or cocaine use disorder (cud). 2022-05-28 2023-08-13 human
Nuria García-Marchena, Alberto Marcos, María Flores-López, Mario Moreno-Fernández, Nerea Requena-Ocaña, Oscar Porras-Perales, Sandra Torres-Galván, Pedro Araos, Antonia Serrano, Roberto Muga, Juan Jesús Ruiz-Ruiz, Fernando Rodríguez de Fonseca, Emilio Ambrosio, Francisco Javier Pavón-Moró. Plasma Amino Acid Concentrations in Patients with Alcohol and/or Cocaine Use Disorders and Their Association with Psychiatric Comorbidity and Sex. Biomedicines. vol 10. issue 5. 2022-05-28. PMID:35625874. because most psychiatric disorders and biomarkers show sex differences, we investigated amino acids in men and women with alcohol and/or cocaine use disorders (aud and/or cud) and psychiatric comorbidity. 2022-05-28 2023-08-13 human
Christiann H Gaines, Sarah A Schoenrock, Joseph Farrington, David F Lee, Lucas J Aponte-Collazo, Ginger D Shaw, Darla R Miller, Martin T Ferris, Fernando Pardo-Manuel de Villena, Lisa M Tarantin. Cocaine-Induced Locomotor Activation Differs Across Inbred Mouse Substrains. Frontiers in psychiatry. vol 13. 2022-05-23. PMID:35599758. cocaine use disorders (cud) are devastating for affected individuals and impose a significant societal burden, but there are currently no fda-approved therapies. 2022-05-23 2023-08-13 mouse
Michael Nader, Bernard Johnson, Michael Coller, Jillian Odo. Effects of Co-Use of Nicotine on Cocaine-Food Choice in Socially Housed Female and Male Cynomolgus Monkeys. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 36 Suppl 1. 2022-05-13. PMID:35556750. cocaine use disorder (cud) continues to be a major public health problem worldwide with 2.0 million americans reporting current cocaine use. 2022-05-13 2023-08-13 monkey
Liangsuo Ma, Kathryn A Cunningham, Noelle C Anastasio, James M Bjork, Brian A Taylor, Albert J Arias, Brien P Riley, Andrew D Snyder, F Gerard Moelle. A serotonergic biobehavioral signature differentiates cocaine use disorder participants administered mirtazapine. Translational psychiatry. vol 12. issue 1. 2022-05-06. PMID:35523779. cocaine use disorder (cud) patients display heterogenous symptoms and unforeseeable responses to available treatment approaches, highlighting the need to identify objective, accessible biobehavioral signatures to predict clinical trial success in this population. 2022-05-06 2023-08-13 human
Liangsuo Ma, Kathryn A Cunningham, Noelle C Anastasio, James M Bjork, Brian A Taylor, Albert J Arias, Brien P Riley, Andrew D Snyder, F Gerard Moelle. A serotonergic biobehavioral signature differentiates cocaine use disorder participants administered mirtazapine. Translational psychiatry. vol 12. issue 1. 2022-05-06. PMID:35523779. serotonin regulates attentional bias to cocaine and the serotonergic antagonist mirtazapine decreased activated ec associated with attentional bias, with greater effectiveness in those cud participants carrying the wild-type 5-ht 2022-05-06 2023-08-13 human
Breno Sanvicente-Vieira, Leonardo Melo Rothmann, Nathalia Bianchini Esper, Lucca Pizzato Tondo, Pedro Eugênio Ferreira, Augusto Buchweitz, Alexandre Rosa Franco, Rodrigo Grassi-Oliveir. Sex differences in brain regional homogeneity during acute abstinence in cocaine use disorder. Addiction biology. vol 27. issue 3. 2022-04-26. PMID:35470550. there are significant sex differences in the clinical characteristics of cocaine use disorder (cud). 2022-04-26 2023-08-13 human
Maria Picó-Pérez, Víctor Costumero, Juan Verdejo-Román, Natalia Albein-Urios, José Miguel Martínez-González, Carles Soriano-Mas, Alfonso Barrós-Loscertales, Antonio Verdejo-Garci. Brain networks alterations in cocaine use and gambling disorders during emotion regulation. Journal of behavioral addictions. 2022-04-23. PMID:35460545. cocaine use disorder (cud) and gambling disorder (gd) share clinical features and neural alterations, including emotion regulation deficits and dysfunctional activation in related networks. 2022-04-23 2023-08-13 Not clear